Global Opioid-Induced Constipation Market Growth 2025-2031

Global Opioid-Induced Constipation Market Growth 2025-2031

The global Opioid-Induced Constipation market size is predicted to grow from US$ 2707 million in 2025 to US$ 3581 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.

Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.

In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.

LP Information, Inc. (LPI) ' newest research report, the “Opioid-Induced Constipation Industry Forecast” looks at past sales and reviews total world Opioid-Induced Constipation sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioid-Induced Constipation sales for 2025 through 2031. With Opioid-Induced Constipation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid-Induced Constipation industry.

This Insight Report provides a comprehensive analysis of the global Opioid-Induced Constipation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid-Induced Constipation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioid-Induced Constipation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid-Induced Constipation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid-Induced Constipation.

This report presents a comprehensive overview, market shares, and growth opportunities of Opioid-Induced Constipation market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others

Segmentation by Application:
Hospital
Pharmacy
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Opioid-Induced Constipation market?

What factors are driving Opioid-Induced Constipation market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Opioid-Induced Constipation market opportunities vary by end market size?

How does Opioid-Induced Constipation break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.